Advertisement

Topic - Robert Kadlec

Related Stories

This photo shows the outside of a Charleston, S.C., condominium belonging to Eugene Zurlo on Monday, Oct. 19, 2020. The Trump administration recently gave the longtime Republican political donor seed money to test a possible COVID-19-fighting blood plasma technology, noting Zurlo's &quot;manufacturing facilities&quot; in Charleston. An AP investigation found no manufacturing facilities. The company operates out of Zurlo's condo. He and his partners may now be in line for as much as $65 million in taxpayer money. (AP Photo/Meg Kinnard)

Trump admin funds plasma company based in owner’s condo

By RICHARD LARDNER and JASON DEAREN - Associated Press

This June 15, 2020 photo shows a bottle and tablets of Pepcid antacid in Washington. The U.S. government's Pepcid project has revealed what critics describe as the Trump administration’s disregard for science and anti-corruption rules meant to guard against taxpayer dollars going to political cronies or funding projects that aren’t rigorously designed. (AP Photo/Patrick Semansky)

Pepcid as a virus remedy? Trump admin’s $21M gamble fizzled

By RICHARD LARDNER and JASON DEAREN - Associated Press

In this March 2020 file photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP) ** FILE **

U.S. government anticipated to run out of remdesivir by end of June

By Shen Wu Tan - The Washington Times